Case Study: Unlock the potential of bispecific T cell engagers

T cells attacking cancer

Discover the groundbreaking findings from a study on bispecific T cell engagers conducted by The Jackson Laboratory. This case study delves into the tools available for assessing cytokine release and tumour growth inhibition. Explore the implications of donor-specific responses and how this knowledge can optimise the development of immunomodulatory therapeutics.

Download this Case Study to learn:

  • The correlation between cytokine release and tumour growth inhibition in the context of bispecifics
  • How donor-specific responses impact the efficacy and safety profiles of immunomodulatory therapeutics
  • The potential risk of toxicity associated with high cytokine release and its impact on patient outcomes

Don’t miss this opportunity to gain valuable insights into the future of bispecifics and the advancement of immuno-oncology therapeutics.

Download now.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free